Thrilled to see our study where we investigated resistance to mutant-specific KRAS inhibition in PDAC across patients specimens and multiple preclinical models. Grateful for the support from our academic and industry partners!
@CD_AACR In their paper, @Julien__Dilly, Megan Hoffman, @laleh_abbassi, Ziyue Li, @FraHeavenView quoted post on X
@SriRaghavanMD @jonathan_nowak @peterswinter Stephanie Dougan @andrewaguirremd et al identify mechanisms of resistance to KRAS inhibition in pancreatic cancer doi.org/10.1158/2159-8… @DanaFarber